State Board of Pharmacy advances compounding regulation package to 15-day comment period after hours-long debate

The California State Board of Pharmacy on Jan. 8 approved moving a package of revised compounding regulations to a 15-day public comment period, following hours of staff briefings, board discussion and more than two dozen public comments from hospitals, pharmacists, patient advocates and associations.

The package, which the board referred to as a set of second/third modified texts, would reorganize and update numerous California Code of Regulations sections (including proposed changes to sections 1735, 1736, 1737 and 1738) to align state rules with federal law and United States Pharmacopeia (USP) compounding chapters while preserving higher California patient-safety standards where they exist. President Sung Oh said the board’s mandate requires it to prioritize public protection. "The board is a consumer protection agency charged with administering and enforcing pharmacy law," he said.

Why it matters: the changes address a wide range of compounding practices — nonsterile and sterile compounding, hazardous-drug handling, radiopharmaceuticals and limited flavoring exemptions — and include provisions stakeholders said could affect access to medications for hospitalized patients, veterinary patients, and populations using compounded products (including firefighters and some patients seeking nebulized or IV therapies). Some commenters urged broader exemptions or clearer paths for specific products; others warned that certain requirements would raise costs or reduce access.

What the board approved and delegated

Maria (board member) moved that the board accept staff responses to comments received during the 30-day comment period, approve the recommended modified text for a 15-day comment period as directed by the board, and delegate authority to members Serpa and Barker (and the Enforcement and Compounding Committee chair working with staff) to review additional comments and recommend actions to the full board. The motion was seconded and carried unanimously by roll call vote. The official action recorded: approved and sent the package out for a 15-day comment period and delegated review authority to…